Skip to main content
  • Percutaneous Versus Surgical Pulmonic Valve Implantation for Right Ventricular Outflow Tract Dysfunction

    Highlights

    • The number of patients requiring invasive interventions for right ventricular outflow tract (RVOT) dysfunction increasing.
    • The percutaneous pulmonic valve implantation (PPVI) applications for RVOT dysfunction are expanding.
    • PPVI appears to be a safe alternative treatment option for RVOT dysfunction compared to surgical implantation.

    Abstract

    Background/purpose

    Percutaneous pulmonic valve implantation (PPVI) is an alternative treatment strategy to surgical pulmonic valve implantation (SPVI) for right ventricular outflow tract(RVOT) dysfunction. This study sought to compare outcomes of both treatment strategies.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details